Company Filing History:
Years Active: 1998
Title: Andreas Rummelt: Innovator in Pulmonary Administration
Introduction
Andreas Rummelt is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of pulmonary administration of medications.
Latest Patents
Rummelt holds a patent for a unique formulation of Ciclosporin designed for pulmonary administration. This patent details the orthorhombic crystal form of Ciclosporin, designated as 'CY-A/X-III'. It is intended for the treatment of obstructive or inflammatory airway diseases, such as asthma. The patent also covers the preparation processes and pharmaceutical uses of crystalline Ciclosporin in spheroidal particulate form, as well as its application in aerosol propellants.
Career Highlights
Andreas Rummelt is associated with Sandoz GmbH, a leading company in the pharmaceutical industry. His work focuses on innovative drug delivery systems that enhance the efficacy of treatments for respiratory conditions.
Collaborations
Rummelt has collaborated with esteemed colleagues, including John Morley and Martin List, to advance research and development in his field.
Conclusion
Andreas Rummelt's contributions to the pharmaceutical industry, particularly through his patent on Ciclosporin for pulmonary administration, highlight his role as an innovator in improving treatment options for respiratory diseases. His work continues to influence the development of effective therapies in this critical area of healthcare.